Quarterly Call Option Transactions in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during . The information is specifically focused on institutions that hold call options of Protagonist Therapeutics, Inc.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | 69,200 | 0 | 69,200 | 204,500 | 0 | 204,500 | -135,300 | |
| Q4 2022 | 142,300 | 0 | 142,300 | 10,300 | 0 | 10,300 | 132,000 | |
| Q1 2023 | 321,200 | 477,300 | 798,500 | — | 798,500 | |||
| Q2 2023 | 267,400 | 84,500 | 351,900 | 290,300 | 0 | 290,300 | 61,600 | |
| Q3 2023 | — | 214,500 | 0 | 214,500 | -214,500 | |||
| Q4 2023 | 11,100 | 0 | 11,100 | 8,200 | 0 | 8,200 | 2,900 | |
| Q1 2024 | — | 495,300 | 0 | 495,300 | -495,300 | |||
| Q2 2024 | 1,800 | 6,400 | 8,200 | 21,300 | 0 | 21,300 | -13,100 | |
| Q3 2024 | 16,800 | 41,100 | 57,900 | 2,400 | 0 | 2,400 | 55,500 | |
| Q4 2024 | 27,200 | 167,000 | 194,200 | — | 194,200 | |||
| Q1 2025 | 147,900 | 800,000 | 947,900 | — | 947,900 | |||
| Q2 2025 | 0 | 146 | 146 | 306,100 | 0 | 306,100 | -305,954 | |
| Q3 2025 | 18,861 | 0 | 18,861 | 170,500 | 0 | 170,500 | -151,639 | |